ArticleJACC. Case reports2026
Percutaneous Debulking of Left Atrial Appendage Occlusion Device-Associated Thrombi and Vegetation.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Percutaneous Mechanical Aspiration of Left-Sided Intracardiac Masses for Prohibitive Surgical Candidates: A Single-Center Experience.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Article
- Late Infection of a Left Atrial Appendage Occlusion Device Detected by Transesophageal Echocardiography.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe incidence of prosthetic device endocarditis has increased with the emergence of percutaneous modalities used for the treatment of structural heart disease. The AngioVac mechanical aspiration system has been used to percutaneously debulk native valve, prosthetic valve, and prosthetic device-associated thrombi as well as vegetations in the setting of endocarditis. However, there are limited descriptions of its use in left-sided prosthetic device-associated infected thrombi and vegetation. CASE SUMMARY: We describe 2 patients who underwent successful percutaneous debulking of left atrial appendage occlusion device-associated thrombi and vegetation in the setting of refractory infective endocarditis with the AngioVac mechanical aspiration system. DISCUSSION: Minimally invasive thrombectomy/debulking with the AngioVac system appears to be a safe and effective alternative to cardiac surgery for the management of high-risk patients with left-sided intracardiac thrombi. TAKE-HOME MESSAGES: Patients with left atrial appendage occlusion device implantation may be at risk for device-associated thrombus in the setting of infective endocarditis. Percutaneous thrombectomy with the AngioVac mechanical aspiration system may be a safe and effective alternative to cardiac surgery for the management of high-risk patients with left-sided intracardiac thrombi.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.